SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-25-122513 from Vireo Growth Inc. (VREOF)

Vireo Growth Inc.
Date: Dec. 18, 2025 · CIK: 0001771706 · Accession: 0001104659-25-122513

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-292025

Date
December 18, 2025
Author
Tyson Macdonald
Form
CORRESP
Company
Vireo Growth Inc.

Letter

VIREO GROWTH INC.

209 SOUTH 9 TH STREET

MINNEAPOLIS, MINNESOTA 55402

VIA EDGAR

December 18, 2025

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Attn: Lauren Hamill

Re: Vireo Growth Inc.

Registration Statement on Form S-3 (File No. 333-292025)

Request for Acceleration of Effective Date

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Vireo Growth Inc. (the "Company") hereby requests that the Securities and Exchange Commission (the "Commission") accelerate the effective date of the above-referenced Registration Statement on Form S-3 (the "Registration Statement") so that the Registration Statement will be declared effective as of 4:01 p.m. Eastern time, on December 19, 2025, or as soon as practicable thereafter. The Company hereby authorizes Nicole A. Edmonds or Thomas M. Rose, both of whom are attorneys at the Company's outside legal counsel, Troutman Pepper Locke LLP, to orally modify or withdraw this request for acceleration.

Once the Registration Statement has been declared effective, please orally confirm that event with Ms. Edmonds at (804) 339-1847 or Mr. Rose at (757) 687-7715.

Thank you for your assistance in this matter.

Very truly yours,
Vireo Growth Inc.

Show Raw Text
CORRESP
 1
 filename1.htm

 VIREO GROWTH INC.

 209 SOUTH 9 TH STREET

 MINNEAPOLIS, MINNESOTA 55402

 VIA EDGAR

 December 18, 2025

 Securities and Exchange Commission

 Division of Corporation Finance

 Office of Life Sciences

 100 F Street, N.E.

 Washington, D.C. 20549

 Attn: Lauren Hamill

 Re:
 Vireo Growth Inc.

 Registration Statement on Form S-3 (File No. 333-292025)

 Request for Acceleration of Effective Date

 Ladies and Gentlemen:

 Pursuant to Rule 461
under the Securities Act of 1933, as amended, Vireo Growth Inc. (the "Company") hereby requests that the Securities and Exchange
Commission (the "Commission") accelerate the effective date of the above-referenced Registration Statement on Form S-3
(the "Registration Statement") so that the Registration Statement will be declared effective as of 4:01 p.m. Eastern
time, on December 19, 2025, or as soon as practicable thereafter. The Company hereby authorizes Nicole A. Edmonds or Thomas M. Rose,
both of whom are attorneys at the Company's outside legal counsel, Troutman Pepper Locke LLP, to orally modify or withdraw this
request for acceleration.

 Once the Registration Statement
has been declared effective, please orally confirm that event with Ms. Edmonds at (804) 339-1847 or Mr. Rose at (757) 687-7715.

 Thank you for your assistance
in this matter.

 Very truly yours,

 Vireo Growth Inc.

 /s/ Tyson Macdonald

 Name:
 Tyson Macdonald

 Title:
 Chief Financial Officer

 cc (via email):
 John Mazarakis, Chief Executive Officer, Vireo Growth Inc. Thomas M. Rose, Troutman Pepper Locke LLP Nicole A. Edmonds, Troutman Pepper Locke LLP